AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Director's Dealing Nov 30, 2018

3258_dirs_2018-11-30_4f033de6-69fe-42ab-8d5d-2c7c322805bd.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Bittium Corporation: Notification of Managers' Transactions

Stock exchange release

Free for publication on November 30, 2018 at 5:00 pm (CET+1)

Bittium Corporation: Notification of Managers' Transactions

Person subject to the notification requirement

Name: Erkki Veikkolainen Position: Member of the Board of Directors

Notification type: Initial Notification Reference number: 743700NFG5W5I59OVX65_20181129141828_2

Issuer: Bittium Corporation LEI: 743700NFG5W5159OVX65

Transaction date: November 28, 2018 Venue: XHEL

Instrument: Share ISIN: FI0009007264 Nature of transaction: Receipt of a Share-Based Incentive

Transaction details

  • (1) Volume: 900 Unit price: EUR 6.68000
  • (2) Volume: 914 Unit price: EUR 6.68000
  • (3) Volume: 440 Unit price: EUR 6.68000

Aggregated transactions

Volume: 2 254 Volume weighted average price: EUR 6.68000

Transaction date: November 28, 2018

Venue: BATE Instrument: Share ISIN: FI0009007264 Nature of transaction: Receipt of a Share-Based Incentive

Transaction details

  • (1) Volume: 130 Unit price: EUR 6.68000
  • (2) Volume: 130 Unit price: EUR 6.68000

Aggregated transactions

Volume: 260 Volume weighted average price: EUR 6.68000

Oulu, November 30, 2018 Hannu Huttunen CEO

Further information:

Kari Jokela CLO Tel. +358 40 344 5258

Distribution:

Nasdaq Helsinki Ltd Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Bittium also offers healthcare technology products and services for the measurement of and monitoring of biosignals in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.